Andlauer Healthcare Group Inc. (TSE:AND) Given Average Rating of “Moderate Buy” by Brokerages

Shares of Andlauer Healthcare Group Inc. (TSE:ANDGet Free Report) have been assigned an average recommendation of “Moderate Buy” from the seven analysts that are currently covering the stock, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is C$48.57.

A number of brokerages have recently commented on AND. TD Securities lifted their target price on shares of Andlauer Healthcare Group from C$53.00 to C$54.00 and gave the company a “buy” rating in a report on Thursday, November 7th. Scotiabank boosted their price objective on shares of Andlauer Healthcare Group from C$43.00 to C$44.00 in a research note on Thursday, November 7th.

Check Out Our Latest Stock Report on Andlauer Healthcare Group

Andlauer Healthcare Group Stock Performance

Shares of Andlauer Healthcare Group stock opened at C$44.01 on Tuesday. The firm’s fifty day simple moving average is C$42.91 and its 200-day simple moving average is C$40.70. The stock has a market capitalization of C$822.99 million, a price-to-earnings ratio of 28.95 and a beta of 0.66. Andlauer Healthcare Group has a 12 month low of C$36.43 and a 12 month high of C$44.92. The company has a debt-to-equity ratio of 41.86, a current ratio of 1.35 and a quick ratio of 1.66.

Andlauer Healthcare Group Company Profile

(Get Free Report

Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.

Featured Articles

Analyst Recommendations for Andlauer Healthcare Group (TSE:AND)

Receive News & Ratings for Andlauer Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andlauer Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.